Spectrum Pharmaceuticals (SPPI) PT, Estimate Cut at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Spectrum Pharma (SPPI) Tops Q4 EPS by 25c
March 13, 2015 7:24 AM EDTSpectrum Pharma (NASDAQ: SPPI) reported Q4 EPS of $0.09, $0.25 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $51.7 million versus the consensus estimate of $48.5 million.
For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.
... More